Table 3 AhR-high and patients’ clinical characteristics

From: The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy

Variable

Odds ratio

95% confidence interval

P values

Gender

5.422

0.412–71.339

0.199

Age

1.094

0.011–112.872

0.970

Smoking

5.889

0.288–120.5

0.250

Histology

0.957

0.322–2.840

0.937

TNM stage

1.356

0.495–3.714

0.553

Beneficial effect

14.568

2.530–83.896

0.003

PD-L1

6.520E9

0

0.999

TMB

2.646

0.160-43.869

0.497

  1. The association between AhR-high and clinical characteristics of the 37 patients treated with pembrolizumab was analyzed by multivariate logistic analyses
Back to article page